For Medical Practitioners AU - geneType™
menu

Are you ready to get started with geneType?

The first step is to setup an account to trial geneType™ at your practice.

Register as a provider

Take the first step towards personalised, preventative healthcare

Knowing your patients’ personalised risk enables you to develop a health plan with them to reduce their risk of serious disease. Select from the tests below to take the first step to managing your patients’ risk.

Breast Cancer

Find out if your patients are at increased risk of developing breast cancer

Learn more

Colorectal Cancer

Find out if your patients are at increased risk of developing bowel(colorectal) cancer

Learn more

Ovarian Cancer

Find out if your patients are at increased risk of developing a ovarian cancer

Learn more

Pancreatic Cancer

geneType™ provides lifetime and 10-year risk scores for pancreatic cancer

Learn more

Melanoma

geneType™ provides lifetime and 10-year risk scores for melanoma

Learn more

Prostate Cancer

Find out if your patients are at increased risk of developing a prostate cancer

Learn more

Coronary Artery Disease

Find out if your patients are at increased risk of developing coronary artery disease

Learn more

Type 2 Diabetes

Find out if your patients are at increased risk of developing type 2 diabetes

Learn more

Multi-Risk Test

Find out if your patients are at increased risk of developing a wide range of cancers as well as heart disease and type 2 diabetes

Learn more

Pancreatic Cancer

geneType™ provides your chances of developing pancreatic cancer

Learn more

Melanoma

geneType™ provides your chances of developing melanoma

Learn more

Atrial Fibrillation

geneType™ provides your chances of developing atrial fibrillation

Learn more
Sample patient report

One report.
Actionable insights.

We provide a comprehensive risk assessment report that will assist you in developing a personalised health plan for your patients.

Key features of a geneType™ report include:

  • Quick identification of your patient’s lifetime risk score and 5-, 8- or 10-year risk depending on the condition.
  • Interpretation of these risk scores in the context of your local guideline recommendations to assist with clinical decision making about screening and risk-reducing strategies.
  • A polygenic risk score: this score is based on genetic data and is integrated into the overall risk score. It is typically not included in traditional risk assessment models.

Scientific Advisory Board

To ensure our tests are of the highest clinical value, Rhythm Biosciences has enlisted the experience and expertise of senior scientific and medical leaders from around the world. They help us tailor our tests to reflect the strongest scientific evidence. Together can advance the field. personalised, preventative health solutions.

Professor Jon Emery

MBBCh MA DPhil FRACGP MRCGP

Research & Education Lead, Primary Care Integration, Victorian Comprehensive Cancer Centre Herman Chair of Primary Care Cancer Research, University of Melbourne

Professor Finlay Macrae AO

MBBS, MD, FRACP, FRCP, AGAF MWGO

Principal Fellow and Professor, Department of Medicine, University of Melbourne, and Head of Colorectal Medicine and Genetics, The Royal Melbourne Hospital

Testing is simple

Step 1

Register as a provider; our team will provide clinical education and other resources as needed.

We will send kits to your clinic to have on hand.

Step 2

Discuss geneType™ with your patient.

Would geneType™ help them qualify for additional risk reduction strategies?

Step 3

Complete the Test Requisition form, collect a saliva sample from the patient with the collection kit provided and return both to Rhythm.

You will have the option to use a paper requisition, or a secure, compliant portal to complete the ordering process.

Step 4

Leave the rest to us.

We will notify you when your patient’s results are ready.

You will have the option to request a consult with a genetic counsellor, whether to review your patient’s results and/or to follow-up with your patient, as needed.

Register as a geneType™ provider

*Patient eligibility dependent on personal medical history, age and sex

Interested in ordering more than one disease? Order geneType™ Multi-Test.

The Multi-Risk suite of tests is for adults 40-85 years of age. At maximum, a woman would be eligible for eight diseases in the panel; a man would be eligible for seven. Starting at age 30, a patient may qualify for geneType’s™ cancer risk assessments only.

A genetic counsellor
on your team.

A genetic counsellor is available to help your geneType™ patients understand the geneType™ test and interpret their results.

For medical practitioners who order geneType™ test, you and your patients have the option to speak with a genetic counsellor when their results are ready.

For patients who order through our telehealth partner, they need to speak with our genetic counsellor to have their results released.

Our goal is to support both medical practitioners and patients through this journey. This is not a test-and-forget approach.

If you have technical questions, or questions around a patient’s clinical report, our genetic counsellor and Medical Affairs Team is available to you.